Fulgent Genetics (FLGT) Net Margin (2015 - 2026)

Fulgent Genetics has disclosed Net Margin across 12 years of filings, most recently posting 34.58% for Q2 2026.

• In Q2 2026, Net Margin fell 1141.0% year-over-year to 34.58%; the TTM figure through Jun 2026 stood at 35.01% (down 1819.0% YoY), while the FY2025 annual figure was 18.75%, down 369.0% from the prior year.
• Net Margin came in at 34.58% for Q2 2026 at Fulgent Genetics, up from 34.9% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 47.95% in Q1 2022 to a low of 5854.5% in Q4 2025.
• Average Net Margin over 5 years is 346.65%, with a median of 18.48% recorded in 2023.
• Year-over-year, Net Margin surged 17403 bps in 2024 and slumped 584677 bps in 2025.
• Over 5 years, Net Margin stood at 28.8% in 2022, then slumped by 531 bps to 181.76% in 2023, then jumped by 96 bps to 7.73% in 2024, then plunged by 75680 bps to 5854.5% in 2025, then jumped by 99 bps to 34.58% in 2026.
• Per Business Quant data, the three most recent Net Margin figures were 34.58% in Q2 2026, 34.9% in Q1 2026, and 5854.5% in Q4 2025.